LearnGlossaryMarketStocksSuperinvestorsSign in

HQL

Tekla Life Sciences Investors

Financial Services · $575M market cap

Verdict

We can't put a fair value on HQL right now. It's an investment fund (a closed-end fund or business development company). A fund is worth what its holdings are worth (its net asset value), which our methods don't measure.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth3.0% a year✗
Equity per share growth0.6% a year✗
Sales growth3.1% a year✗
Free cash flow growth—?
Return on invested capital11.1%✓

Follow HQL

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Tekla Life Sciences Investors

Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of…

Asset Management

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works